Abstract
The introduction of a beta-carbonyl group to the C-2 side chain of S-DABO led to the finding of a series of novel potent anti-HIV agent. Some derivatives proved to be highly effective in inhibiting HIV-1 replication at nanomolar concentrations. Furthermore, the novel S-DABOs differ from the classical NNRTIs in that some compounds are active against both HIV-1 and HIV-2. They might interfere with another target or at least act on RT in a different way as compared to typical NNRTIs.
MeSH terms
-
Anti-HIV Agents / chemistry*
-
Anti-HIV Agents / pharmacology
-
Cell Line
-
HIV Reverse Transcriptase / antagonists & inhibitors*
-
HIV Reverse Transcriptase / metabolism
-
Humans
-
Pyrimidines / chemistry
-
Pyrimidines / pharmacology
-
Pyrimidinones / chemistry
-
Pyrimidinones / pharmacology
-
Reverse Transcriptase Inhibitors / chemistry*
-
Reverse Transcriptase Inhibitors / pharmacology
Substances
-
Anti-HIV Agents
-
DABO 546
-
Pyrimidines
-
Pyrimidinones
-
Reverse Transcriptase Inhibitors
-
HIV Reverse Transcriptase